HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toll-like receptor 4 plays a central role in cardiac dysfunction during trauma hemorrhage shock.

Abstract
Cardiac dysfunction is a major consequence that contributes to the high mortality of trauma-hemorrhage (TH) patients. Recent evidence suggests that innate immune and inflammatory responses mediated by Toll-like receptors (TLRs) play a critical role in the pathophysiologic mechanisms of acute organ dysfunction during TH. This study investigated the role of TLR4 in cardiac dysfunction following TH. Toll-like receptor 4-deficient (TLR4-/-, n = 7/group) and age-matched wild-type (WT, n = 8/group) mice were subjected to TH that was induced by soft tissue injury and blood withdrawal from the jugular vein to a mean arterial pressure of 35 ± 5 mmHg. Cardiac function and mean arterial pressure were measured with a Millar system before, during, and after blood withdrawal. Sham surgical-operated mice served as control (WT, n = 9/group; TLR4-/-, n = 10/group). Cardiac function in WT mice was significantly reduced following TH. However, cardiac function was well preserved in TLR4-/- mice. Administration of a TLR4 antagonist (3 mg/kg) to WT mice also significantly attenuated TH-induced cardiac dysfunction. Western blot showed that either TLR4-/- or TLR4 antagonist markedly attenuated TH-induced decreases in the levels of phosphorylated-Akt in myocardium. In addition, inhibition of TLR4 attenuated TH-induced myocardial nuclear factor κB-binding activity as well as lung myeloperoxidase activity and tumor necrosis factor α production. The data indicate that TLR4 plays a central role in TH-induced cardiac dysfunction. Toll-like receptor 4 deficiency or TLR4 inhibition attenuated cardiac dysfunction following TH, which may involve activation of the phosphoinositide 3-kinase/Akt signaling and decrease in nuclear factor κB-binding activity. Toll-like receptor 4 antagonism may be a new and novel approach for the treatment and management of cardiac dysfunction in TH patients.
AuthorsXia Zhang, Chen Lu, Ming Gao, Xinyun Cao, Tuanzhu Ha, John H Kalbfleisch, David L Williams, Chuanfu Li, Race L Kao
JournalShock (Augusta, Ga.) (Shock) Vol. 42 Issue 1 Pg. 31-7 (Jul 2014) ISSN: 1540-0514 [Electronic] United States
PMID24569510 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • E5564
  • Lipid A
  • NF-kappa B
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Heart (physiopathology)
  • Hemodynamics (drug effects, physiology)
  • Lipid A (analogs & derivatives, pharmacology)
  • Male
  • Mice, Knockout
  • NF-kappa B (metabolism)
  • Neutrophil Infiltration (drug effects, physiology)
  • Phosphorylation (drug effects, physiology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Shock, Hemorrhagic (etiology, metabolism, physiopathology)
  • Soft Tissue Injuries (complications)
  • Toll-Like Receptor 4 (antagonists & inhibitors, deficiency, physiology)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: